Arturo Molina

Arturo Molina

Direttore Tecnico/Scientifico/R&S presso PROTAGONIST THERAPEUTICS, INC.

Patrimonio netto: 1 M $ in data 30/04/2024

65 anni
Health Technology
Health Services
Consumer Services

Provenienza dei contatti di primo grado di Arturo Molina

EntitàTipo di entitàSettore Industriale
Public Company Pharmaceuticals: Major 76
Public Company Pharmaceuticals: Major 24
Public Company Biotechnology 20
18
Extinct Pharmaceuticals: Major 18
Subsidiary Pharmaceuticals: Major 12
7
Subsidiary Biotechnology 7
3
Extinct Pharmaceuticals: Major 3
2
Subsidiary Medical/Nursing Services 2
Stanford Medical Alumni Association
1
Private Company 1

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Arturo Molina tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
Biotechnology

James Panek

William Rastetter

William Young

Samuel Saks

V. Lawlis

Melissa Morandi

Frank Lee

Jane Chung

Corporate Officer/Principal

Corporate Officer/Principal

Chief Operating Officer

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Sales & Marketing

Pharmaceuticals: Major

Connie Matsui

Anne Cook

Faheem Hasnain

William Rastetter

William Young

Cecil B. Pickett

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

Chairman

Director/Board Member

Chief Tech/Sci/R&D Officer

University of Michigan College/University

James Panek

John Cox

Heidi Hunter

Jon Wigginton

Christopher Watt

Graduate Degree

Masters Business Admin

Undergraduate Degree

Doctorate Degree

Masters Business Admin

Biotechnology

Thomas F. Keller

Craig Eric Schneier

Lawrence C. Best

Burt Adelman

Robert A. Hamm

Director/Board Member

Human Resources Officer

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

AMGEN INC. Pharmaceuticals: Major

Carol Gallagher

David Hallal

Melissa Morandi

Alessandra Cesano

Diana Landa

Sales & Marketing

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

General Counsel

University of California, Berkeley College/University

Michael Gilman

Michael Dybbs

Sarah Noonberg

Regina Cheng

Doctorate Degree

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Yale University College/University

Daniel Swisher

Eric S. Hoffman

Pratik Multani

Mark Meltz

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

ANNEXON, INC. Pharmaceuticals: Major

Carol Gallagher

William Young

Thomas Wiggans

William Waddill

Director/Board Member

Chairman

Chairman

Director/Board Member

College/University

William Rastetter

Peter Kolchinsky

Dinah Sah

Pratik Multani

Doctorate Degree

Doctorate Degree

Doctorate Degree

Corporate Officer/Principal

ALZA CORPORATION Pharmaceuticals: Major

Samuel Saks

Daniel Swisher

Carter J. King

Suneel Gupta

Chairman

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

Marsha Fanucci

Joseph Lobacki

Peter Wirth

Corporate Officer/Principal

Corporate Officer/Principal

General Counsel

DICERNA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Peter Kolchinsky

Thomas Haagen

Ulrich Christian Otte

Director/Board Member

Director/Board Member

Director/Board Member

MERCK & CO., INC. Pharmaceuticals: Major

Cecil B. Pickett

Eric W. Kimble

Scott Anthony Climes

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Stanford University College/University

Connie Matsui

Sarah O'Dowd

Pat Basu

Masters Business Admin

Graduate Degree

Corporate Officer/Principal

PUMA BIOTECHNOLOGY, INC. Pharmaceuticals: Major

Alan Auerbach

Charles R. Eyler

Alessandra Cesano

Chief Executive Officer

Director of Finance/CFO

Director/Board Member

BIOMARIN PHARMACEUTICAL INC. Biotechnology

William Young

V. Lawlis

Sarah Noonberg

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Pharmaceuticals: Major

Harold Selick

Dinesh Patel

William Waddill

Chairman

Chief Executive Officer

Director/Board Member

College/University

James Basta

Craig Berman

Joseph Mara

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

CUBIST PHARMACEUTICALS INC Pharmaceuticals: Major

Robert Perez

Eric W. Kimble

Ben Harshbarger

Chief Executive Officer

Sales & Marketing

General Counsel

PDL BIOPHARMA, INC. Biotechnology

Faheem Hasnain

Samuel Saks

Harold Selick

Chief Executive Officer

Director/Board Member

Chairman

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Faheem Hasnain

Dinesh Patel

Jon Wigginton

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

University of Illinois College/University

Samuel Saks

William Waddill

Pat Basu

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

ARIAD PHARMACEUTICALS, INC. Biotechnology

Michael Gilman

Timothy Clackson

John McCabe

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Comptroller/Controller/Auditor

Massachusetts Institute of Technology College/University

Michael Gilman

William Rastetter

Dinah Sah

Undergraduate Degree

Corporate Officer/Principal

Undergraduate Degree

The University of California, San Francisco College/University

Lewis Williams

Harold Selick

Sarah Noonberg

Corporate Officer/Principal

Corporate Officer/Principal

Doctorate Degree

PFIZER, INC. Pharmaceuticals: Major

Carol Gallagher

Bonne Adams

Patrick F. Kelly

Sales & Marketing

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

University of California, Santa Barbara College/University

Melissa Morandi

Carter J. King

Mohammad Masjedizadeh

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

Miscellaneous Commercial Services

Cecil B. Pickett

Selwyn Vickers

Wayne Frederick

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

MIRATI THERAPEUTICS Biotechnology

Carol Gallagher

Faheem Hasnain

Shalini Sharp

Director/Board Member

Chairman

Director/Board Member

Investment Banks/Brokers

William Rastetter

Allen Kamer

Bryan Giraudo

Consultant / Advisor

Director/Board Member

Corporate Officer/Principal

PRINCIPIA BIOPHARMA INC. Pharmaceuticals: Major

Richard Miller

Michael Dybbs

Mohammad Masjedizadeh

Founder

Director/Board Member

Chief Tech/Sci/R&D Officer

Hospital/Nursing Management

Lawrence C. Best

Lewis Williams

Pratik Multani

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Boston University College/University

Alan Auerbach

Andrea DiFabio

Michael Dambach

Undergraduate Degree

Undergraduate Degree

Masters Business Admin

Harvard Law School College/University

Peter Wirth

Daniel Char

Graduate Degree

Graduate Degree

Biotechnology

Samuel Saks

Carter J. King

Director/Board Member

Director of Finance/CFO

FATE THERAPEUTICS, INC. Biotechnology

William Rastetter

Pratik Multani

Chairman

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Carol Gallagher

Faheem Hasnain

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Michael Gilman

Michael Dambach

Founder

Director/Board Member

University of New Hampshire College/University

David Hallal

Michael Dambach

Undergraduate Degree

Undergraduate Degree

The University of Colorado College/University

Craig Eric Schneier

Bonne Adams

Doctorate Degree

Undergraduate Degree

UNITEDHEALTH GROUP INC. Managed Health Care

Allen Kamer

Pat Basu

Corporate Officer/Principal

Private Equity Investor

Biotechnology

Michael Gilman

Samantha Truex

Founder

Corporate Officer/Principal

Biotechnology

Michael Gilman

David Hallal

Director/Board Member

Chairman

AUSPEX PHARMACEUTICALS INC Pharmaceuticals: Major

Samuel Saks

Phillip Schneider

Director/Board Member

Director/Board Member

Statistiche

Distribuzione geografica

Stati Uniti 49
Australia 2
Israele 2

Settori

Health Technology 31
Consumer Services 14
Finance 4
Commercial Services 3
Health Services 3

Posizioni

Director/Board Member 501
Corporate Officer/Principal 250
Independent Dir/Board Member 178
Chairman 135
Chief Executive Officer 93
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA